ABATTIS BIOCEUTICALS CORP. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | -99.00% |
|
-.--% | -.--% |
| 2020 | Abattis Bioceuticals Corp. Reports Earnings Results for the Full Year Ended September 30, 2019 | CI |
| 2019 | Abattis Bioceuticals Corp. Announces Board Changes | CI |
Quotes 5-day view
Delayed Quote OTC Markets| 2024-04-24 | 2024-04-25 | |
|---|---|---|
| Last | 0.0001 $ | 1.0E-6 $ |
| Volume | 700 | 2 500 |
| Change | +∞% | -99.00% |
| Opening | 0.00 | 0.00 |
| High | 0.00 | 0.00 |
| Low | 0.00 | 0.00 |
Performance
| 1 day | -99.00% |
Volumes
marketsDaily volume
2 500
Estimated daily volume
2 500
Avg. Volume 20 sessions
12 737
Daily volume ratio
0.20
Avg. Volume 20 sessions USD
0.01
Record volume 1
14 758 060
Record volume 2
11 843 400
Record volume 3
10 305 900
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (USD)
476
Net sales (CAD)
356 876
Net sales (USD)
260 070
Free-Float
99.64 %
Free-Float capitalization (USD)
478
Average Daily Capital Traded
0%
Highs and lows
1 week
0.00
0.00
1 month
0.000.00
Current year
0.000.00
1 year
0.000.00
3 years
0.000.03
5 years
0.000.08
10 years
0.001.09
Indicators
STIM
RSI 9 days
47.06
RSI 14 days
48.15
Sector Comparison - Medical Farming
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -99.00% | -.--% | - | - | 476 | ||
| 0.00% | +4.41% | +46.09% | +255.00% | 284M | ||
| 0.00% | -7.30% | +30.93% | +29.59% | 270M | ||
| -9.59% | -0.75% | +53.49% | -2.94% | 198M | ||
| -19.99% | +19.63% | -28.99% | -34.14% | 146M | ||
| -17.11% | +6.62% | +56.76% | +51.02% | 142M | ||
| 0.00% | 0.00% | -28.57% | +25.00% | 120M | ||
| -2.43% | +13.07% | +142.28% | +32.91% | 140M | ||
| 0.00% | +28.57% | +3.85% | -40.00% | 89.69M | ||
| -.--% | -.--% | +150.00% | -77.48% | 75.33M | ||
| -2.73% | -13.59% | +11.25% | - | 68.6M | ||
| 0.00% | +11.11% | +122.22% | +100.00% | 59.91M | ||
| 0.00% | +31.25% | +8.62% | +10.53% | 56.19M | ||
| +6.41% | 0.00% | 0.00% | +10.67% | 54.3M | ||
| Average | -10.32% | +5.29% | +43.69% | +30.01% | ||
| Weighted average by Cap. | -4.36% | +5.67% | +42.54% | +53.42% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | -.--% | ||
| 2023 | -.--% | ||
| 2022 | -.--% | ||
| 2021 | -99.99% | ||
| 2020 | +177.78% | ||
| 2019 | -91.68% | ||
| 2018 | -87.31% | ||
| 2017 | +285.79% | ||
| 2016 | +129.73% | ||
| 2015 | -67.93% | ||
| 2014 | +525.00% | ||
| 2013 | -77.14% | ||
| 2012 | -11.02% |
- Stock Market
- Equities
- ATTBF Stock
- Quotes Abattis Bioceuticals Corp.
